ABCG1 and type 2 diabetes mellitus: Further supporting this, a comparative epigenome-wide association study in statin-treated versus non-treated T2DM patients identified 79 differentially methylated CpG sites, with three—cg17901584 (DHCR24), cg27243685 (ABCG1), and cg05119988 (SC4MOL)—showing strong associations with statin exposure (Schrader et al., 2021).